AARVI vs SICAGEN: Stock Comparison
SICAGEN INDIA is the larger company by market capitalisation. AARVI ENCON shows a higher ROE, faster revenue growth and lower leverage, while SICAGEN INDIA shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AARVI leads 7; SICAGEN leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AARVI | SICAGEN |
|---|---|---|
| Sector | Services | — |
| Industry | Diversified Commercial Services | — |
Price
| Metric | AARVI | SICAGEN |
|---|---|---|
| Live Price | ₹136.87 | ₹55.28 |
| Day Change | 1.78% | -3.15% |
| Volume | 5,251 | 11,971 |
| 52-Week High | ₹168.4 | ₹74.06 |
| 52-Week Low | ₹115.99 | ₹46.55 |
| Distance from 52W High | -18.72% | -25.36% |
Valuation
| Metric | AARVI | SICAGEN |
|---|---|---|
| Market Cap | ₹206 Cr | ₹218 Cr |
| P/E Ratio | 13.03x | 11.41x |
| P/B Ratio | 1.62x | 0.47x |
| EPS | ₹4.03 | ₹1.75 |
| Book Value | ₹95.71 | ₹125.09 |
| Dividend Yield | 0% | 1.81% |
Growth
| Metric | AARVI | SICAGEN |
|---|---|---|
| Revenue Growth (TTM YoY) | 19.2% | 0% |
| EPS Growth (TTM YoY) | 55.7% | 0% |
| Qtr Sales Growth | 0% | 2.9% |
| Qtr Profit Growth | 0% | 55.38% |
Profitability & Leverage
| Metric | AARVI | SICAGEN |
|---|---|---|
| ROE | 12.4% | 3.65% |
| ROCE | 10.22% | 4.43% |
| Net Margin | 2.94% | 1.86% |
| Operating Margin | 3.51% | 3.9% |
| Debt to Equity | 0.19x | 0.29x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | AARVI | SICAGEN |
|---|---|---|
| Promoter Holding | 73.36% | 23.92% |
| FII Holding | 0% | 2.47% |
| DII Holding | 0% | 0.58% |
| Public Holding | 26.64% | 35.81% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AARVI ENCON and SICAGEN INDIA.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.